In the face of tough competition from biggies like HUL and P&G, smaller FMCG firms, including Ajanta Pharma and Ozone Ayurvedics, are selling off their popular flagship brands as they find it increasingly tough to grow them.
While Ozone Ayurvedics is looking at selling off its flagship personal care brand 'Nomarks', Mumbai-based Ajanta Pharma has recently sold off its popular energising capsule '30-Plus' due to change in priorities and as the brand has become stagnant.
"The issue is if the management is unable to support the brand or not finding it profitable, the best route is to sell it off," Shirish Pardeshi, an analyst with Anand Rathi Financial Services told PTI.
As the brand grows, it is important to have the kind of distribution and scale of economy that it requires to compete with much stronger brands, he added.
Ozone Ayurvedics, which sells personal care brand 'Nomarks', said it is willing to sell it off to an appropriate buyer which has the right network to make the product more lucrative.
'Nomarks' competes with the likes of 'Fair & Lovely' from HUL and Reckitt Benckiser's anti marks cream 'Clearasil'.
"If we find any firm, with great distribution channels, who wants to buy (Nomarks), we will consider it," Ozone Ayurvedics Chairman and Managing Director S C Sehgal said, adding till date top six to seven firms have approached them.
He claims the brand, which garners an annual sales of Rs 60 crore is still profitable. It is just that his firm has not exploited the true potential 'Nomarks' as it has been focusing on other areas.
Similarly, Ajanta Pharma sold off '30-Plus' to leading FMCG firm Dabur, which has a more stronger distribution channel and has been aggressively looking at expanding its healthcare portfolio.
The company said the OTC brand has not grown though it still enjoys a strong recall among consumers.
"With the change in focus at Ajanta Pharma, 30-Plus' was stagnant for some time, though it still enjoys a strong recall as an energiser brand," Ajanta Pharma Managing Director Yogesh Agrawal said.
According to Pardeshi of Anand Rathi, brands like 30-Plus and Nomarks have established themselves among consumers.
"But it has to go beyond in terms of their geographic expansion or making it more larger than what it is. Management needs to do justice to it," he said.
Last year, despite having strong brands like Moov, Krack and Set Wet, Paras Pharmaceuticals was acquired by British firm Reckitt Benckiser for Rs 3,260 crore.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
